false
Catalog
The 8-hour MOUD Training - PART 1 - 4/22/2024
Presentation Slides - Part 1 with Dr. Morrone
Presentation Slides - Part 1 with Dr. Morrone
Back to course
Pdf Summary
The document on PCSS Medications for Opioid Use Disorder (MOUD) Training introduces Dr. William Morrone's qualifications and the funding source. It addresses addiction as a chronic disorder and discusses factors contributing to substance use disorders. The negative impacts on healthcare, importance of evidence-based treatment, and effectiveness of medications like methadone, buprenorphine, and naltrexone are emphasized.<br /><br />Information on the pharmacology and usage of these medications is presented, stressing the need for thorough patient evaluation. Building a positive relationship with patients, using non-stigmatizing language, and providing ongoing support are highlighted. A case study of a university student with opioid use disorder is included, recommending medication-assisted treatment (MAT) with buprenorphine/naloxone, aiming to reduce cravings, manage withdrawal, and prevent relapse.<br /><br />The treatment plan involves individualized care with a focus on achieving and maintaining abstinence, improving academic performance, and addressing mental health issues. The initial prescription of buprenorphine/naloxone is suggested to be lower (2mg/0.5mg) for better monitoring and support initially. The overall approach involves a combination of medication, counseling, and support strategies tailored to the patient's needs to promote recovery and well-being.
Keywords
PCSS Medications for Opioid Use Disorder Training
Dr. William Morrone qualifications
Funding source
Addiction as chronic disorder
Substance use disorders factors
Medications: methadone, buprenorphine, naltrexone
Pharmacology of medications
Patient evaluation importance
Medication-assisted treatment (MAT)
Individualized care for opioid use disorder
×
Please select your language
1
English